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Foreword 
P. Fiorani 
Although aortic graft infection is fortunately an in- 
frequent event, because of its high morbidity and 
mortality it is one of the most feared complications 
in vascular surgery. Recently published therapeutic 
proposals based upon more advanced and sensitive 
diagnostic techniques, along with more specific, ap- 
propriate and effective pharmacological management, 
seem to offer patients with prosthetic graft infections 
a more promising outlook. 
Most congresses on vascular surgery today allocate 
program space to one or more presentations or sessions 
on the subject, invariably provoking lively discussion. 
Everyone who faces the challenging problem of pro- 
sthetic graft infections has tried to find new surgical 
strategies as alternatives to traditional explantation of 
the infected graft and extra-anatomic revascularisation 
of the lower limbs. These innovations have been fully 
dealt with in numerous, well documented pub- 
lications. What has been lacking until now is a forum 
offering a direct exchange of opinions. 
The need for a really wide-ranging debate on these 
controversial points prompted us to organise a 2-day 
symposium in Rome on 15-16 December 1995. The 
meeting brought together the leading international 
experts on graft infection. Attendance was excellent 
and it attracted colleagues from all over the world. 
This success was due mainly to announcements of the 
Symposium given in the Annales de Chirurgie, European 
Journal of Vascular and Endovascular Surgery, the Journal 
of Vascular Surgery and International Angiology, whom 
I take this opportunity to thank. 
To make the most of the limited time available, 
instead of attempting a complete survey of aortic graft 
infections the programme concentrated on specific 
topics with ample time for discussion. To achieve this 
aim we regrettably had to reject some topics that lay 
outside the scope of the symposium. 
On behalf of the organisers of the symposium I 
would like to thank the University of Rome for kindly 
allowing us to use its conference centre. I also wish 
to thank the companies who not only made it possible 
to organise the symposium, but also contributed to 
publication of the proceedings in the European Journal 
of Vascular and Endovascular Surgery. 
Finally let me thank the medical colleagues listed 
below who were the principal participants in the sym- 
posium. 
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